LicianPro

PLRX holders · CITADEL ADVISORS LLC 13F · PLRX stock

CITADEL ADVISORS LLC Pliant Therapeutics Inc (PLRX) 13F holding

CITADEL ADVISORS LLC reported 3,226,599 PLRX shares valued at $4.1M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest PLRX 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the PLRX holders table.

PLRX reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-313,226,599$4.1MCOM
2025-12-312,583,332$3.2MCOM
2025-09-302,339,468$3.5MCOM
2025-06-302,355,899$2.7MCOM

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.